Pascal Soriot, AstraZeneca CEO (Photographer: Chris Ratcliffe/Bloomberg via Getty Images)
April 23, 2024 11:00 AM EDT
People
Bioregnum
Pharma

Pas­cal So­ri­ot’s been push­ing for US-sized CEO pay for more than a decade. Now he’s fi­nal­ly get­ting it

Back in 2013, Pas­cal So­ri­ot’s first full year at the helm of a tot­ter­ing As­traZeneca, he land­ed a pay pack­age worth about $5.5 mil­lion. By …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

TRENDING NOW

Deputy FDA chief mulls shak­ing up PDU­FA reau­tho­riza­tion struc­ture

Up­dat­ed: No­vo Nordisk CEO to step down amid stock de­cline, time­line for suc­ces­sor un­known

Low­er at­ten­dance at cell and gene ther­a­py con­fer­ence mir­rors chal­lenged in­dus­try

The in­side sto­ry of the six-month sprint to cre­ate the first cus­tom CRISPR ther­a­py for one in­fant’s rare dis­ease

'Go ahead and do it': Top RFK Jr. deputy dares drug­mak­ers that might pull man­u­fac­tur­ing over new price pres­sure

No­vo Nordisk’s glob­al obe­si­ty leader is mov­ing on; Flag­ship biotech gets CEO from Schol­ar Rock

A service from the Financial Times